rivive

Generic: naloxone hydrochloride

Labeler: harm reduction therapeutics, inc.
NDC Directory HUMAN OTC DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivive
Generic Name naloxone hydrochloride
Labeler harm reduction therapeutics, inc.
Dosage Form SPRAY
Routes
NASAL
Active Ingredients

naloxone hydrochloride 3 mg/.1mL

Manufacturer
Harm Reduction Therapeutics, Inc.

Identifiers & Regulatory

Product NDC 82954-0100
Product ID 82954-0100_4e308ade-33a2-4daa-acdd-af1559b90c17
Product Type HUMAN OTC DRUG
Marketing Category NDA
Application Number NDA217722
Listing Expiration 2027-12-31
Marketing Start 2024-01-02

Pharmacologic Class

Classes
opioid antagonist [epc] opioid antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 829540100
Hyphenated Format 82954-0100

Supplemental Identifiers

RxCUI
2673091
UNII
F850569PQR

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivive (source: ndc)
Generic Name naloxone hydrochloride (source: ndc)
Application Number NDA217722 (source: ndc)
Routes
NASAL
source: ndc

Resolved Composition

Strengths
  • 3 mg/.1mL
source: ndc
Packaging
  • 2 VIAL, SINGLE-DOSE in 1 CARTON (82954-0100-1) / .1 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

naloxone hydrochloride (3 mg/.1mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["NASAL"], "spl_id": "4e308ade-33a2-4daa-acdd-af1559b90c17", "openfda": {"unii": ["F850569PQR"], "rxcui": ["2673091"], "spl_set_id": ["1c4f1b9d-1c70-4666-a90e-2f5d2c670d4d"], "manufacturer_name": ["Harm Reduction Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 VIAL, SINGLE-DOSE in 1 CARTON (82954-0100-1)  / .1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "82954-0100-1", "marketing_start_date": "20240102"}], "brand_name": "RiVive", "product_id": "82954-0100_4e308ade-33a2-4daa-acdd-af1559b90c17", "dosage_form": "SPRAY", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "82954-0100", "generic_name": "naloxone hydrochloride", "labeler_name": "Harm Reduction Therapeutics, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "RiVive", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "3 mg/.1mL"}], "application_number": "NDA217722", "marketing_category": "NDA", "marketing_start_date": "20240102", "listing_expiration_date": "20271231"}